🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Alport Syndrome

Genotype-Phenotype Correlations in Patients With Alport Syndrome NCT04947813n/a1 site📍 Shanghai Xinhua Hospital, Shanghai Jiao Tong University School of Me… Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport) NCT05927467n/a1 site📍 Paris Institut National de la Santé Et de la Recherche Médicale, … Phase 3 Clinical Trial With Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients NCT05944016Phase 316 sites📍 Heidelberg📍 München📍 München University Hospital Goettingen · Tests: Dapagliflozin, Placebo ASF Alport Patient Registry NCT06526741n/a1 site📍 Scottsdale Alport Syndrome Foundation · Tests: Longitudinal data collection Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases NCT05003986Phase 247 sites📍 Los Angeles📍 Wilmington📍 Miami Travere Therapeutics, Inc. · Tests: Sparsentan, Sparsentan, Sparsentan Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome NCT02378805n/a1 site📍 Göttingen University Hospital Goettingen · Tests: ACE-inhibitor, Angiotensin-receptor blocker (ARB), HMG-Coenzyme inhibitor (statin), Spironolactone or Finerenone, Paric… NEPTUNE Match Study NCT04571658NA16 sites📍 Atlanta📍 Chicago📍 Kansas City University of Michigan · Tests: Communication EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety NCT07523581Phase 211 sites📍 Los Angeles📍 Stanford📍 Denver Eloxx Pharmaceuticals, Inc. · Tests: Exaluren Periodontal Disease in Rare Renal Disorders (PERIO-RA-RE) NCT07575347n/a1 site📍 Bucharest Stefan Lujinschi · Tests: Observational assessment National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy